Status:
COMPLETED
Feasibility Study CORPPS
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Santelys Association
ENGIE
Conditions:
Esophageal Neoplasm
Laryngeal Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
The incidence of cancer in France has increased by +135% to reach nearly 400,000 new cases in 2018. The ten-year cancer control strategy 2021-2030 and the health innovation plan have defined strategic...
Eligibility Criteria
Inclusion
- Hospitalized for initial surgical management of esophageal or laryngeal cancer
- Admitted to a conventional ward after partial oesophagectomy or total laryngectomy in a neoplastic setting
- Patient giving consent to participate in the study
- Affiliated to the compulsory health insurance scheme, regardless of the scheme
Exclusion
- Patient who did not follow the previously described course of care prior to admission to the ward
- Esophagectomy with total circular pharyngo-laryngectomy
- Total esogastrectomy
- Illiterate, visually impaired patient
- Minor, or adult under guardianship or curatorship, under judicial protection, person deprived of liberty
Key Trial Info
Start Date :
April 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 19 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05406024
Start Date
April 3 2023
End Date
April 19 2024
Last Update
December 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universtaire
Lille, France, 59037